FR2181426B1 - - Google Patents

Info

Publication number
FR2181426B1
FR2181426B1 FR7212036A FR7212036A FR2181426B1 FR 2181426 B1 FR2181426 B1 FR 2181426B1 FR 7212036 A FR7212036 A FR 7212036A FR 7212036 A FR7212036 A FR 7212036A FR 2181426 B1 FR2181426 B1 FR 2181426B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7212036A
Other versions
FR2181426A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut Pasteur de Lille
Original Assignee
Institut Pasteur de Lille
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut Pasteur de Lille filed Critical Institut Pasteur de Lille
Priority to FR7212036A priority Critical patent/FR2181426B1/fr
Priority to JP5909872A priority patent/JPS5549573B2/ja
Priority to US342932A priority patent/US3925545A/en
Priority to BE129232A priority patent/BE797300A/fr
Priority to NL7304219A priority patent/NL7304219A/xx
Priority to GB1527573A priority patent/GB1422973A/en
Priority to CA167,599A priority patent/CA1034496A/fr
Priority to LU67331A priority patent/LU67331A1/xx
Priority to AT287173A priority patent/AT332967B/de
Priority to DE2316911A priority patent/DE2316911C3/de
Priority to DK187673A priority patent/DK143250C/da
Priority to CH498673A priority patent/CH579630A5/xx
Priority to YU934/73A priority patent/YU39706B/xx
Publication of FR2181426A1 publication Critical patent/FR2181426A1/fr
Application granted granted Critical
Publication of FR2181426B1 publication Critical patent/FR2181426B1/fr
Priority to US05/639,926 priority patent/US4016252A/en
Priority to CA299,914A priority patent/CA1042793A/fr
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
FR7212036A 1972-04-06 1972-04-06 Expired FR2181426B1 (fr)

Priority Applications (15)

Application Number Priority Date Filing Date Title
FR7212036A FR2181426B1 (fr) 1972-04-06 1972-04-06
JP5909872A JPS5549573B2 (fr) 1972-04-06 1972-06-15
US342932A US3925545A (en) 1972-04-06 1973-03-20 Process for preparing adsorbed vaccines
BE129232A BE797300A (fr) 1972-04-06 1973-03-26 Procede de preparation de vaccins adsorbes
NL7304219A NL7304219A (fr) 1972-04-06 1973-03-27
GB1527573A GB1422973A (en) 1972-04-06 1973-03-29 Process for preparing adsorbed vaccines
LU67331A LU67331A1 (fr) 1972-04-06 1973-03-30
CA167,599A CA1034496A (fr) 1972-04-06 1973-03-30 Preparation d'un vaccin par absorption sur un gel a base de phosphate de calcium
AT287173A AT332967B (de) 1972-04-06 1973-04-02 Verfahren zur herstellung von adsorbierten vaccinen
DE2316911A DE2316911C3 (de) 1972-04-06 1973-04-04 Verfahren zur Herstellung eines fur die Adsorption von Impfstoff geeigneten wäßrigen Calciumphosphatgels
DK187673A DK143250C (da) 1972-04-06 1973-04-06 Vandig gel af calciumphosphat til brug som adsorptionsmiddel for antigener samt fremgangsmaade til fremstilling heraf
CH498673A CH579630A5 (fr) 1972-04-06 1973-04-06
YU934/73A YU39706B (en) 1972-04-06 1973-04-06 Process for obtaining a highly adosorbing aqueous gel of calcium phosphate
US05/639,926 US4016252A (en) 1972-04-06 1975-12-11 Calcium phosphate gel for adsorbing vaccines
CA299,914A CA1042793A (fr) 1972-04-06 1978-03-29 Gel de phosphate de calcium pour absorber les vaccins

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7212036A FR2181426B1 (fr) 1972-04-06 1972-04-06

Publications (2)

Publication Number Publication Date
FR2181426A1 FR2181426A1 (fr) 1973-12-07
FR2181426B1 true FR2181426B1 (fr) 1974-12-20

Family

ID=9096409

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7212036A Expired FR2181426B1 (fr) 1972-04-06 1972-04-06

Country Status (13)

Country Link
US (1) US3925545A (fr)
JP (1) JPS5549573B2 (fr)
AT (1) AT332967B (fr)
BE (1) BE797300A (fr)
CA (1) CA1034496A (fr)
CH (1) CH579630A5 (fr)
DE (1) DE2316911C3 (fr)
DK (1) DK143250C (fr)
FR (1) FR2181426B1 (fr)
GB (1) GB1422973A (fr)
LU (1) LU67331A1 (fr)
NL (1) NL7304219A (fr)
YU (1) YU39706B (fr)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4016252A (en) * 1972-04-06 1977-04-05 Institut Pasteur Calcium phosphate gel for adsorbing vaccines
US4070454A (en) * 1973-05-04 1978-01-24 Agence Nationale De Valorisation De La Recherche (Anvar) Vaccines, the process for preparing the same and the applications thereof
DE2843963A1 (de) * 1978-10-09 1980-04-24 Merck Patent Gmbh Im koerper resorbierbare geformte masse auf basis von kollagen und ihre verwendung in der medizin
DE2807132C2 (de) * 1978-02-20 1983-11-03 Battelle-Institut E.V., 6000 Frankfurt Implantierbares Pharmaka-Depot
FR2502496A2 (fr) * 1981-03-30 1982-10-01 Pasteur Institut Fractions nouvelles extraites de bacteries aerobies, douees de proprietes antitumorales, antibacteriennes et inductrices d'interferon, et leur procede de preparation
HU188847B (en) * 1983-02-22 1986-05-28 Human Oltoanyagtermeloe Es Kutato Intezet,Hu Process for producing liophylized combined vaccines
FR2543439B1 (fr) * 1983-03-31 1985-09-27 Pasteur Institut Perfectionnement a la preparation d'un gel de phosphate de calcium utile a l'adsorption d'antigenes
US8333996B2 (en) 1995-05-19 2012-12-18 Etex Corporation Calcium phosphate delivery vehicle and adjuvant
US8728536B2 (en) 1996-10-16 2014-05-20 Etex Corporation Chemotherapeutic composition using nanocrystalline calcium phosphate paste
CA2361421A1 (fr) 1999-02-03 2000-08-10 Biosante Pharmaceuticals, Inc. Particules therapeutiques de phosphate de calcium et procedes de fabrication et d'utilisation associes
US20040258763A1 (en) * 1999-02-03 2004-12-23 Bell Steve J.D. Methods of manufacture and use of calcium phosphate particles containing allergens
US20020054914A1 (en) * 1999-02-03 2002-05-09 Tulin Morcol Compositions and methods for therapuetic agents complexed with calcium phosphate and encased by casein
US20030185892A1 (en) * 2001-08-17 2003-10-02 Bell Steve J. D. Intraocular delivery compositions and methods
JP5189763B2 (ja) 2003-04-11 2013-04-24 エテックス コーポレーション 骨誘導性骨材料
BRPI0507680A (pt) 2004-02-13 2007-07-17 Nod Pharmaceuticals Inc partìculas de fosfato de cálcio terapêuticas e métodos de fabricação e uso das mesmas
WO2005117919A2 (fr) 2004-04-15 2005-12-15 Etex Corporation Pates de phosphate de calcium a durcissement retarde
WO2006050368A2 (fr) 2004-11-01 2006-05-11 Biosante Pharmaceuticals, Inc. Particules therapeutiques de phosphate de calcium destinees a la medecine esthetique ou cosmetique, et procedes de fabrication et d'utilisation
US8147860B2 (en) 2005-12-06 2012-04-03 Etex Corporation Porous calcium phosphate bone material
FR2912396B1 (fr) * 2007-02-09 2011-08-26 Solvay Procede de production d'un reactif phosphocalcique, reactif obtenu et son utilisation
KR102032002B1 (ko) 2011-11-23 2019-10-14 머크 샤프 앤드 돔 코포레이션 알루미늄 히드록시포스페이트 아주반트의 제조 방법

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2364579A (en) * 1941-11-12 1944-12-05 Lederle Lab Inc Hog cholera vaccine
US3435112A (en) * 1966-06-21 1969-03-25 Norden Lab Inc Repository vaccine and method of preparing the same
FR1604134A (fr) * 1967-09-26 1971-07-12

Also Published As

Publication number Publication date
LU67331A1 (fr) 1973-06-15
YU39706B (en) 1985-04-30
DE2316911C3 (de) 1980-06-12
DE2316911B2 (de) 1979-03-15
FR2181426A1 (fr) 1973-12-07
NL7304219A (fr) 1973-10-09
GB1422973A (en) 1976-01-28
DK143250B (da) 1981-08-03
CH579630A5 (fr) 1976-09-15
ATA287173A (de) 1976-02-15
DE2316911A1 (de) 1973-10-25
CA1034496A (fr) 1978-07-11
US3925545A (en) 1975-12-09
YU93473A (en) 1982-02-28
JPS4913322A (fr) 1974-02-05
BE797300A (fr) 1973-09-26
JPS5549573B2 (fr) 1980-12-12
DK143250C (da) 1981-12-14
AT332967B (de) 1976-10-25

Similar Documents

Publication Publication Date Title
JPS496399A (fr)
FR2181426B1 (fr)
JPS4890004U (fr)
JPS499337U (fr)
JPS4913859U (fr)
JPS499115A (fr)
JPS5312112Y2 (fr)
JPS48108051U (fr)
JPS4875366A (fr)
JPS4912598U (fr)
JPS4957147U (fr)
JPS4965702U (fr)
JPS4983394U (fr)
CH560966A5 (fr)
CH572429A5 (fr)
CH561428A5 (fr)
CH561786A5 (fr)
CH564416A5 (fr)
CH560959A5 (fr)
CH565246A5 (fr)
CH565301A5 (fr)
CH566825A (fr)
CH569167A5 (fr)
CH1486873A4 (fr)
CH578838A5 (fr)

Legal Events

Date Code Title Description
ST Notification of lapse
RC Opposition against decision of lapse
DA Annulment of decision of lapse